CoChat

New Approaches to Modeling Bipolar Disorder

Einat, Haim, PhD, Belmaker, Robert H., MD, Manji, and Husseini K., MD · 2025 · Psychopharmacology Bulletin
Cited by 60

The DOI matches its Crossref record.

Abstract

Modeling in animals is an invaluable tool in exploring the pathophysiology of human diseases and developing better therapies. Models can be generated using a variety of pharmacological, behavioral, and genetic approaches, but they all require extensive subsequent validation. Ideally, validation should be based on three axes: face validity (commonalities between the behavioral features of the model and the human disorder being modeled), predictive validity (the specificity and degree to which drugs effective in humans have a corresponding effect in the model), and construct validity (a possible common mechanistic theory that can explain both the model and the human disorder being modeled). Most existing models for psychiatric disorders were developed from a face validity starting point, wherein a researcher noticed the appearance of a rodent behavior similar to a human pathological behavior and subsequently undertook investigations of predictive and construct validity. Some representative models developed in this manner include the hyperactivity (spontaneous or pharmacologically induced), sensitization, and sleep-deprivation models. In this review, we critically appraise the existing animal models for bipolar disorder, emphasizing their strengths and limitations. Furthermore, we discuss the technological advances that have led to an increased awareness of the roles of signal transduction pathways and neurotrophic cascades in the pathophysiology and treatment of bipolar disorder. New construct validity–driven models focusing on signaling pathways include models based on perturbations of G proteins, phosphoinositide signaling, and mitogen-activated protein (MAP) kinase cascades. These new models hold much promise in delineating the underlying pathophysiology of bipolar disorder and in the development of novel, improved therapeutics. Psychopharmacology Bulletin. 2003;37(1):47-63.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64719/pb.4195

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Einat, H., PhD, Belmaker, R. H., MD, Manji, A. H. K., & MD
Venue
Psychopharmacology Bulletin
Published
2025-08-12
Volume
37
Issue
1
Pages
47-63
ISSN
  • 0048-5764 (ISSN-L)
  • 2472-2448
OpenAlex
W2419144483
Cited by
60
References
0
FWCI
0.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.